Accident Compensation Corp lowered its holdings in shares of Clorox Company (The) (NYSE:CLX) by 41.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,205 shares of the company’s stock after selling 7,201 shares during the period. Accident Compensation Corp’s holdings in Clorox were worth $1,346,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Asset Management One Co. Ltd. grew its stake in Clorox by 0.8% in the third quarter. Asset Management One Co. Ltd. now owns 245,374 shares of the company’s stock valued at $32,339,000 after acquiring an additional 1,939 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its stake in Clorox by 1.6% in the third quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 61,955 shares of the company’s stock valued at $8,172,000 after acquiring an additional 1,000 shares during the period. AMP Capital Investors Ltd grew its stake in Clorox by 8.9% in the third quarter. AMP Capital Investors Ltd now owns 39,013 shares of the company’s stock valued at $5,146,000 after acquiring an additional 3,180 shares during the period. Allianz Asset Management GmbH grew its stake in Clorox by 417.8% in the third quarter. Allianz Asset Management GmbH now owns 63,868 shares of the company’s stock valued at $8,425,000 after acquiring an additional 51,534 shares during the period. Finally, Nomura Asset Management Co. Ltd. lifted its holdings in shares of Clorox by 2.8% in the third quarter. Nomura Asset Management Co. Ltd. now owns 67,918 shares of the company’s stock valued at $8,959,000 after purchasing an additional 1,873 shares in the last quarter. 73.42% of the stock is owned by institutional investors and hedge funds.

A number of research firms have recently weighed in on CLX. Jefferies Group restated a “hold” rating and issued a $137.00 target price (up previously from $136.00) on shares of Clorox in a report on Wednesday, August 9th. Royal Bank Of Canada restated a “hold” rating and issued a $115.00 target price on shares of Clorox in a report on Sunday, October 8th. BMO Capital Markets restated an “outperform” rating on shares of Clorox in a report on Tuesday, September 12th. Consumer Edge upgraded Clorox from a “neutral” rating to an “outperform” rating in a report on Friday, November 10th. Finally, Morgan Stanley dropped their target price on Clorox from $138.00 to $128.00 and set an “equal weight” rating on the stock in a report on Thursday, November 2nd. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company. Clorox has a consensus rating of “Hold” and an average price target of $128.72.

In other Clorox news, SVP Michael R. Costello sold 10,574 shares of the business’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the sale, the senior vice president now directly owns 34,867 shares in the company, valued at $4,742,260.67. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Matthew T. Laszlo sold 20,051 shares of the business’s stock in a transaction on Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the sale, the senior vice president now owns 10,896 shares in the company, valued at $1,421,492.16. The disclosure for this sale can be found here. Insiders own 1.00% of the company’s stock.

Shares of Clorox Company (NYSE:CLX) opened at $145.05 on Thursday. The company has a market capitalization of $18,652.26, a price-to-earnings ratio of 26.07, a P/E/G ratio of 3.93 and a beta of 0.43. Clorox Company has a fifty-two week low of $113.95 and a fifty-two week high of $145.32. The company has a current ratio of 1.10, a quick ratio of 0.77 and a debt-to-equity ratio of 3.02.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, topping the Zacks’ consensus estimate of $1.41 by $0.05. The business had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.48 billion. Clorox had a return on equity of 161.59% and a net margin of 11.84%. Clorox’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same period last year, the company posted $1.36 earnings per share. analysts anticipate that Clorox Company will post 5.6 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be paid a $0.84 dividend. The ex-dividend date is Tuesday, January 23rd. This represents a $3.36 annualized dividend and a dividend yield of 2.32%. Clorox’s payout ratio is presently 61.88%.

ILLEGAL ACTIVITY NOTICE: This story was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another website, it was copied illegally and reposted in violation of United States & international trademark and copyright legislation. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/12/07/clorox-company-the-clx-position-reduced-by-accident-compensation-corp.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.